+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Primaquine for radical cure of Plasmodium vivax and Plasmodium ovale malaria: an observational survey (2008-2010)



Primaquine for radical cure of Plasmodium vivax and Plasmodium ovale malaria: an observational survey (2008-2010)



Journal of Travel Medicine 20(2): 134-136



Since 2008, the French guidelines have promoted the systematic use of 30 mg/day of primaquine for the radical cure of Plasmodium vivax and Plamodium ovale infections. We observed three relapses in 10 patients with P vivax acquired in French Guiana. No relapses were seen in West African P ovale patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036796304

Download citation: RISBibTeXText

PMID: 23464724

DOI: 10.1111/jtm.12009


Related references

Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis. Travel Medicine and Infectious Disease 13(3): 235-240, 2016

Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. American Journal of Tropical Medicine and Hygiene 62(3): 393-395, 2000

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. American Journal of Tropical Medicine and Hygiene 82(4): 542-547, 2010

Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure. International Ophthalmology 39(8): 1767-1782, 2019

Expanding the Use of Primaquine for the Radical Cure of Plasmodium vivax. Clinical Infectious Diseases 67(7): 1008-1009, 2018

An imported malaria case with mixed infection of Plasmodium falciparum, Plasmodium vivax and Plasmodium ovale. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 31(6): 485-486, 2013

Therapeutic failure of primaquine and need for new medicines in radical cure of Plasmodium vivax. Acta Tropica 160: 35-38, 2016

Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malaria Journal 11: 280, 2012

Internal validity of clinical trials for Plasmodium vivax malaria treatment: analysis of evaluation study of in vivo Plasmodium vivax emergence of resistance to standard doses of primaquine. Revista Da Sociedade Brasileira de Medicina Tropical 36(3): 383-386, 2003

Molecular characterization and phylogenetic analysis of Plasmodium vivax , Plasmodium falciparum , Plasmodium ovale , Plasmodium malariae and Plasmodium cynomolgi. Journal of Parasitic Diseases 41(1): 230-236, 2017

An observational study of malaria in British travellers: Plasmodium ovale wallikeri and Plasmodium ovale curtisi differ significantly in the duration of latency. Bmj Open 3(5):, 2013

Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India. Journal of Parasitology 88(5): 1042-1044, 2002

Repeated Plasmodium vivax malaria accesses radical treatment by using chloroquine and primaquine in association. Medecine et Armees 23(1): 3-4, 1995

Improving the radical cure of Plasmodium vivax malaria. American Journal of Tropical Medicine and Hygiene 91(1): 3-4, 2014

Failure to radical cure in Plasmodium vivax malaria. Revista Chilena de Infectologia 33(4): 468-471, 2016